ESMO E-Learning and V-Learning
Watch E-Learning and V-Learning webcasts produced by leading oncology experts and take the CME test.
ESMO continually develops E-Learning and V-Learning modules covering a broad range of topics relevant for practising oncologists including:
- Recent discoveries and their impact on current treatments for diverse tumour types
- Oncology clinical case studies and conundrums
- Guidance on implementation of the latest ESMO clinical practise guidelines and incorporation of recent clinical advancements
- Selected oncology highlights from the past year
E-Learning and V-Learning modules less than 2 years are accompanied by a CME test (ESMO members only) awarding 1 ESMO-MORA category 1 point and 1 ACOE (Accreditation Council of Oncology in EU) CME credit on successful completion. ESMO members have the option to print the certificate immediately or store in the myESMO CME bank.
Modules marked as V-Learning contain video presentations to enhance your learning experience.
ESMO E-Learning and V-Learning Modules are the original property of ESMO. Authorship is retained by the module authors. The modules and their constituent slides can not be presented in any form, modified or otherwise, on a platform other than those belonging to ESMO, without prior explicit permission from ESMO. Module PDF files are available for individual download by medical professionals for study and reference purposes only.
|Anti-Cancer Agents & Biologic Therapy - Neuroendocrine Cancers - Pancreatic Cancer||Optimising Outcomes in Gastrointestinal Neuroendocrine Tumours||Mairéad McNamara|
|Central Nervous System Malignancies - Surgery and/or Radiotherapy of Cancer||Management of Patients with Brain Metastases: Focusing on Radiotherapy||Dirk Rades|
|Colon Cancer - Rectal Cancer||Optimising Outcomes for Patients with Advanced Colorectal Cancer||Demetris Papamichael, Stavros Gkolfinopoulos, George Pentheroudakis|
|Translational Research||V-Learning: HER2 Mutations in Cancer||Michail Ignatiadis|
|Lymphomas - Imaging, Diagnosis and Staging||The Lugano Classification recommendations for Hodgkin’s and non-Hodgkin’s lymphoma: Staging, Response Assessment and Follow Up||Francesca Pavanello, Emanuele Zucca|
|Head and Neck Cancers||Prognostic and Predictive Biomarkers in Head & Neck Cancer||Salvatore Alfieri, Lisa Licitra|
|Oesophageal Cancer - Gastric Cancer||Optimising the Assessment and Therapy of Oesophago-Gastric Junction Adenocarcinomas||Elisa Fontana, David Cunningham|
|Anti-Cancer Agents & Biologic Therapy - Head and Neck Cancers - Surgery and/or Radiotherapy of Cancer||Multimodular Treatment in Head & Neck Squamous Cell Carcinoma (HNSCC)||Amanda Psyrri|
|Drug Development - Personalised Medicine||V-Learning: Personalised Medicine in the Context of Drug Development||Hendrik-Tobias Arkenau|
|Anti-Cancer Agents & Biologic Therapy - Gastric Cancer||Optimising Anti-Angiogenic Strategies in Gastric Adenocarcinoma||Christelle de la Fouchardière|
|Breast Cancer - Cancer in Young Adults - Psychosocial Aspects of Cancer||Breast Cancer in Young Women||Flora Stavridi|
|Cancer Aetiology, Epidemiology, Prevention - Cancer in Young Adults - Familial Cancer - Colon Cancer - Rectal Cancer||Colorectal Cancer in Young Adults: The Focus on Hereditary Cancer Syndromes||Emmanouil Saloustros|
|Anti-Cancer Agents & Biologic Therapy - Cancer Immunology and Immunotherapy - Melanoma and other Skin Tumours||New Treatments in Melanoma||Paolo A. Ascierto|
|Lung and other Thoracic Tumours||Thoracic Oncology Highlights 2014||Niels Reinmuth, Martin Reck|
|Breast Cancer - Personalised Medicine - Translational Research||Metabolomics in Cancer, With a Focus on Breast Cancer||Christopher Hart, Angelo Di Leo|